Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07571928 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

Study acronym: NOVA-NOA
StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical interventional study aims to assess whether treatment with with leflutrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) or Inhibin B as a positive predictive biomarker.
Trial Details
NCT Number NCT07571928
Lead Sponsor Martin Blomberg Jensen
Collaborators: ReproNovo SA
Conditions
(from sponsor)		 Infertility Due to Azoospermia, Infertility, Male
Related terms Infertility, Male
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov